A delegation of about 85 global medical professionals, scientists, and policymakers from Harvard University’s “Science of Defeating Malaria” leadership development initiative has praised the establishment of the NASENI-TROMENT Biotechnologies factory, describing it as a major milestone in the fight against malaria and other infectious diseases across Nigeria and Africa.
The international team made the commendation during a guided tour of the state-of-the-art biotechnology facility in Abuja.
Benin Launches Landmark Report to Mark World Malaria Day
The visitors expressed admiration for the factory’s capacity to manufacture Polymerase Chain Reaction (PCR) kits and Rapid Diagnostic Tests (RDTs), describing it as a significant step toward strengthening Africa’s healthcare infrastructure through local innovation.
Speaking during the visit, Chief Executive Officer and Co-Founder of NASENI-TROMENT Biotechnologies, Mr. Selim Hani, explained that the facility is the product of a strategic partnership between the National Agency for Science and Engineering Infrastructure (NASENI) and Troment Nigeria Limited.
He noted that the collaboration is aimed at enhancing Nigeria’s healthcare sovereignty through the local production of diagnostic technologies.
According to Hani, the factory was built from the ground up within 18 months and is dedicated to manufacturing RDTs and in-vitro diagnostic (IVD) products that facilitate the early detection of infectious and public health diseases.
He emphasized that the initiative will contribute significantly to improving healthcare delivery and disease surveillance across the continent.
He disclosed that diagnostic kits under the N-CheckUP brand would be produced for the detection of malaria, Hepatitis B and C, HIV 1 and 2, pregnancy, COVID-19 antigen, typhoid, syphilis, blood glucose levels, and several other medical conditions.
Hani further revealed that the facility has the capacity to produce up to 600 million diagnostic kits annually.
He said the factory would substantially reduce Nigeria’s dependence on imported diagnostic products while increasing the accessibility and affordability of quality healthcare solutions throughout West Africa and the wider African region.
Also speaking during the tour, Technical Partner of NASENI-TROMENT Biotechnologies, Dr. Engin Narinc, described the facility as Africa’s first fully localized Rapid Diagnostic Test kit manufacturing plant.
He stated that every stage of production, from concept development to large-scale manufacturing, is carried out within Africa.
Narinc explained that the end-to-end production process reflects a commitment to delivering world-class diagnostic solutions tailored to Africa’s healthcare needs.
He added that the project demonstrates the continent’s growing capacity to develop and manufacture advanced medical technologies independently.
Leading the visiting delegation, Professor Dyann F. Wirth of Harvard University, one of the world’s foremost malaria researchers, toured various sections of the facility and commended the initiative.
She described the factory as an impressive achievement that would play a crucial role in supporting efforts to eradicate malaria and other public health diseases in Nigeria and across Africa.
The Science of Defeating Malaria leadership programme, currently taking place in Abuja from June 7 to 13, 2026, brings together global health experts, scientists, and policymakers committed to malaria elimination.
PVAC Targets Affordable Malaria Care for Children, Pregnant Women
The visit to the NASENI-TROMENT Biotechnologies factory formed part of the programme’s activities aimed at exploring innovative solutions and partnerships for disease control and eradication.